ibm-research/biomed.sm.mv-te-84m-MoleculeNet-ligand_scaffold-BACE-101 84.6M • Updated Feb 24 • 564 • 3
ibm-research/biomed.sm.mv-te-84m-MoleculeNet-ligand_scaffold-MUV-101 84.6M • Updated Nov 1, 2024 • 8 • 2
ibm-research/biomed.sm.mv-te-84m-MoleculeNet-ligand_scaffold-SIDER-101 84.6M • Updated Nov 1, 2024 • 9 • 2
ibm-research/biomed.sm.mv-te-84m-MoleculeNet-ligand_scaffold-TOX21-101 84.6M • Updated Nov 1, 2024 • 14 • 1
ibm-research/biomed.sm.mv-te-84m-MoleculeNet-ligand_scaffold-LIPOPHILICITY-101 84.6M • Updated Nov 1, 2024 • 681 • 1
ibm-research/biomed.sm.mv-te-84m-MoleculeNet-ligand_scaffold-TOXCAST-101 84.8M • Updated Nov 1, 2024 • 5 • 1
ibm-research/biomed.sm.mv-te-84m-MoleculeNet-ligand_scaffold-CLINTOX-101 84.6M • Updated Nov 1, 2024 • 9 • 1
ibm-research/biomed.sm.mv-te-84m-MoleculeNet-ligand_scaffold-ESOL-101 84.6M • Updated Nov 1, 2024 • 13 • 1
ibm-research/biomed.sm.mv-te-84m-MoleculeNet-ligand_scaffold-BBBP-101 84.6M • Updated Nov 1, 2024 • 47 • 1
ibm-research/biomed.sm.mv-te-84m-MoleculeNet-ligand_scaffold-QM7-101 84.6M • Updated Nov 1, 2024 • 8 • 1
ibm-research/biomed.sm.mv-te-84m-MoleculeNet-ligand_scaffold-FREESOLV-101 84.6M • Updated Nov 1, 2024 • 7 • 1
ibm-research/biomed.sm.mv-te-84m-MoleculeNet-ligand_scaffold-HIV-101 84.6M • Updated Nov 1, 2024 • 10 • 1
ibm-research/biomed.sm.mv-te-84m-ComputationalADME-random-MDR1-MDCK-ER-101 84.6M • Updated Jun 3, 2025 • 7
ibm-research/biomed.sm.mv-te-84m-ComputationalADME-random-SOLUBILITY-101 84.6M • Updated Jun 3, 2025 • 9
upci-ntua/pyrosage-endocrine_disruption_nr-ahr-attentivefp Text Classification • Updated Jun 5, 2025 • 2
upci-ntua/pyrosage-endocrine_disruption_nr-aromatase-attentivefp Text Classification • Updated Jun 5, 2025 • 4
upci-ntua/pyrosage-irritation_corrosion_eye_irritation-attentivefp Text Classification • Updated Jun 5, 2025 • 5
upci-ntua/pyrosage-endocrine_disruption_nr-er-attentivefp Text Classification • Updated Jun 5, 2025 • 5
upci-ntua/pyrosage-endocrine_disruption_nr-ar-attentivefp Text Classification • Updated Jun 5, 2025 • 4